Explore more publications!
Latin American Newswire
Got News to Share?

Latin American Newswire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin American Newswire.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on November 3, 2025

ALPHAMIN ANNOUNCES CAD $0.04 PER SHARE SECOND INTERIM FY2025 DIVIDEND / FILES Q3 2025 FINANCIAL STATEMENTS AND MD&A
November 3, 2025

ALPHAMIN ANNOUNCES CAD $0.04 PER SHARE SECOND INTERIM FY2025 DIVIDEND / FILES Q3 2025 FINANCIAL STATEMENTS AND MD&A

Indeterminate GlobeNewswire
Granting of Incentive Stock Options
November 3, 2025

Granting of Incentive Stock Options

Indeterminate GlobeNewswire
Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
November 3, 2025

Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

Indeterminate GlobeNewswire
Greenlight Re Announces Financial Results for Third Quarter and Nine Months Ended September 30, 2025
November 3, 2025

Greenlight Re Announces Financial Results for Third Quarter and Nine Months Ended September 30, 2025

Indeterminate GlobeNewswire
Pyxis Oncology to Participate in Upcoming Investor Conferences
November 3, 2025

Pyxis Oncology to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in November
November 3, 2025

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in November

Indeterminate GlobeNewswire
James River Announces Third Quarter 2025 Results
November 3, 2025

James River Announces Third Quarter 2025 Results

Indeterminate GlobeNewswire
Invivyd to Host Third Quarter 2025 Financial Results and Corporate Update Call on November 6, 2025
November 3, 2025

Invivyd to Host Third Quarter 2025 Financial Results and Corporate Update Call on November 6, 2025

Indeterminate GlobeNewswire
Arvinas to Present Preclinical Data for ARV-393 at the 2025 American Society of Hematology (ASH) Annual Meeting
November 3, 2025

Arvinas to Present Preclinical Data for ARV-393 at the 2025 American Society of Hematology (ASH) Annual Meeting

Indeterminate GlobeNewswire
Blazpay Phase 3 Crypto presale is Live: Secure AI-Powered Crypto Tokens at $0.009375 Now
November 3, 2025

Blazpay Phase 3 Crypto presale is Live: Secure AI-Powered Crypto Tokens at $0.009375 Now

Indeterminate GlobeNewswire
Organogenesis Applauds CMS’s Significant Step In Payment Reform
November 3, 2025

Organogenesis Applauds CMS’s Significant Step In Payment Reform

Indeterminate GlobeNewswire
Brittany Kaiser to Present at SALT London 2025 on DeFi, Tokenization, and Digital Asset Treasuries
November 3, 2025

Brittany Kaiser to Present at SALT London 2025 on DeFi, Tokenization, and Digital Asset Treasuries

Indeterminate GlobeNewswire
Compass Recovery Launches Enhanced Website to Expand Access to Purpose-Driven Addiction Treatment in Orange County, CA
November 3, 2025

Compass Recovery Launches Enhanced Website to Expand Access to Purpose-Driven Addiction Treatment in Orange County, CA

Indeterminate EIN Presswire
Texas Medicare Meltdown 2025: Premiums Surge and Part D Chaos Hits Hard
November 3, 2025

Texas Medicare Meltdown 2025: Premiums Surge and Part D Chaos Hits Hard

Indeterminate EIN Presswire
Cellectis to Present a Development Update for eti-cel at ASH 2025
November 3, 2025

Cellectis to Present a Development Update for eti-cel at ASH 2025

Indeterminate GlobeNewswire
Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting
November 3, 2025

Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting

Indeterminate GlobeNewswire
Allogene Therapeutics Announces ALPHA3 Trial-in-Progress Poster Presentation at ASH Annual Meeting
November 3, 2025

Allogene Therapeutics Announces ALPHA3 Trial-in-Progress Poster Presentation at ASH Annual Meeting

Indeterminate GlobeNewswire
Corvus Pharmaceuticals to Present Final Data from Soquelitinib Phase 1/1b T Cell Lymphoma Trial at the 67th American Society of Hematology Annual Meeting & Exposition
November 3, 2025

Corvus Pharmaceuticals to Present Final Data from Soquelitinib Phase 1/1b T Cell Lymphoma Trial at the 67th American Society of Hematology Annual Meeting & Exposition

Indeterminate GlobeNewswire
Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition
November 3, 2025

Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition

Indeterminate GlobeNewswire
Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2025 Financial Results 
November 3, 2025

Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2025 Financial Results 

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions